Funding
Series A · Biotech

Generare raises €20m Series A for molecular data

Alven, Daphni, Galion.exe, Teampact Ventures and Vives Partners participated in the financing.

Updated Oct 16, 2026By RoundOS Funding desk

Generare raised €20 million in Series A financing on April 2. Participants included Alven, Daphni, Galion.exe, Teampact Ventures and Vives Partners. The company generates molecular data for drug development.

Funding history

Series A · This round€20M

Sources

  1. Generareprojectstartups.com
  2. tech.eu

Similar rounds

All Biotech rounds →
Guoke Brain-Computer

Beijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.

UndisclosedSeed · Oct 23, 2026
Star Therapeutics

Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need.

$200MPrivate financing · Oct 23, 2026
Pathos AI

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026
Knowledge Work

Tokyo software company developing sales AI agents, an agent operating platform and consulting services for enterprise sales teams.

¥4.8BSeries C debt second close · Oct 23, 2026

Related